Feline polycystic kidney disease (PKD) is an inherited autosomal dominant disease characterized by plural cysts formation in the bilateral kidneys and occasionally in the liver and pancreas \[[@r9]\]. The enlargement of these cysts leads to the development of chronic kidney disease (CKD). The various sized cysts are observed in the renal cortex and medulla of affected cats. The formation and growth of cysts progress slowly, and the renal function gradually deteriorates in the PKD affected cats. The clinical and morphological features of feline PKD are very similar to those of human autosomal dominant polycystic kidney disease (ADPKD) \[[@r15]\]. Therefore, it has been suggested that feline PKD represents a good model for human ADPKD.

Feline PKD was first identified in Persian cats and Persian related breeds \[[@r4], [@r25]\]. Subsequent studies \[[@r21]\] revealed that a mutation from C to A at position 10063 in exon 29 of the feline *PKD1* gene (*PKD1* mutation), which results in a premature stop codon in the mRNA, is the specific cause of PKD. The accumulation of clinical researches on feline PKD revealed that there are many PKD affected cats all over the world. It seems that this disease also spread among the cats of Japan.

Ultrasonographic studies have indicated that the prevalence of PKD in Persian and related cats is about 49.2% in the United Kingdom \[[@r10]\], 43% in Australia \[[@r2]\], and 41.8% in France \[[@r3]\]. Ultrasonography is a good tool for the diagnosis of cystic kidneys. However, PKD is not the only cause of cyst formation in kidneys. Many pathogenic factors such as end stage kidney of chronic nephritis and abnormal condition caused by urinary tract obstruction are involved. Furthermore, kidney diseases that cause pelvic dilation is occasionally misdiagnosed as PKD based on ultrasonography. Therefore, the definitive diagnosis of PKD should be established by genetic testing of the *PKD1* mutation. Although the surveys of cats with PKD diagnosed by genetic testing have been conducted in several countries, the number of studied cats was limited \[[@r14], [@r18], [@r20], [@r21]\], and little information is available on cats carrying the *PKD1* mutation in Japan.

Recent reports \[[@r20]\] have described PKD in feline breeds other than Persians. We previously reported the clinical course and cystic fluid characteristics in a Japanese Domestic Shorthair cat with PKD \[[@r24]\]. It is clinically important to investigate the distribution of feline PKD in other feline breeds of Japan because the cats with the *PKD1* mutation should not be used for breeding. The aims of this study were to investigate the epidemiological characteristics and clinical features of cats with the *PKD1* mutation and to evaluate the prevalence of PKD in Japan.

MATERIALS AND METHODS {#s1}
=====================

Samples
-------

Heparinized blood samples that were sent to Iwate University Veterinary Teaching Hospital for testing the *PKD1* mutation from 2008 to 2015 were used. These samples were collected from referring veterinary clinics located throughout Japan. Information on these cats was obtained from referring veterinarians, including breed, age, sex, and, if available, the presence, location, and number of renal and hepatic cysts, and plasma concentrations of blood urea nitrogen (BUN), creatinine (Cre), and inorganic phosphate (iP). In some cases, ultrasonographic images of kidneys were obtained from the referring veterinarians and the cystic lesions were confirmed.

Information of animals
----------------------

In this study, 377 samples were obtained from cats aged from 0 to 18 years old, and included 166 males, 179 females, and 32 of unknown sex. The breeds included Persian (n=79), Exotic Shorthair (n=71), Scottish Fold (n=69), American Shorthair (n=34), Japanese-mixed (n=48) and the other western-mixed breed cats (n=11). Samples were sent from Hokkaido, Tohoku (Aomori, Iwate, Fukushima), Kanto (Ibaraki, Kanagawa, Saitama, Tochigi, Tokyo, Chiba), Chubu (Niigata, Aichi), Kinki (Osaka, Hyogo, Nara, Shiga, Kyoto), Chugoku (Hiroshima, Shimane), and Kyushu (Kagoshima, Kumamoto) districts.

Of 377 cats examined, 219 cats received ultrasonographic examinations by the referring veterinarians, and 159 of these were reported to have renal cysts and 60 cats were reported to have no cysts. The remaining 158 cats had not undergone ultrasonographic examination. All of the cats were clinically or genetically suspected of PKD by the referring veterinarians, because of abnormal ultrasonography or because they were relatives of PKD affected cats (Persian cats and other breeds including mixed breed are contained).

Genetic testing
---------------

PCR restriction fragment length polymorphism (RFLP) assay was performed on all 377 blood samples at the Department of Veterinary Internal Medicine of Iwate University. Genomic DNA was isolated from heparinized whole blood using a DNA purification kit (DNeasy Blood and Tissue Kit, Qiagen, Hilden, Germany). Exon 29 of the feline *PKD1* was partially amplified by PCR, producing a 559-bp amplicon, according to the Lyons *et al*. \[[@r20]\] protocol. DNA restriction was performed by digestion of 5 *µl* of amplification product in a total reaction volume of 10 *µl* that contained 0.5 *µl* of FastDigest MLyl (Fermentas, Waltham, MA, U.S.A.) and 10×FastDigest buffer (Fermentas) incubated at 37°C for 30 min, followed by inactivation of enzyme at 80°C for 5 min. The RFLP pattern was obtained by running the complete digestion reaction on a 2% agarose gel.

Statistical evaluation
----------------------

The rate (%) of the *PKD1* mutation \[(number of mutation positive cats / total number of cats) ×100\] was calculated for each breed. The sex difference in cats with the *PKD1* mutation and in cats with coinciding hepatic cysts was evaluated by χ^2^ test.

RESULTS {#s2}
=======

Results of genetic testing in relation to the presence of renal cysts
---------------------------------------------------------------------

The results of genetic testing in relation to the presence of renal cysts are listed in [Table 1](#tbl_001){ref-type="table"}Table 1.The result of genetic test in relation to the presence of renal cystsRenal cysts detected by ultrasonographyPresentAbsentNot examinedThe number of cats15960158PKD1 gene mutationPositiveNegativePositiveNegativePositiveNegativeThe number of cats (%)126 (79%)^a)^33 (21%)3 (5%)^a)^57 (95%)21 (13%)^a)^137 (87%)a) Total number of positive cats is 150 (40%).. In total, 150 of 377 (40%) cats carried the *PKD1* mutation; of these, 126 (84%) cats were diagnosed as having renal cysts by ultrasonography, 3 (2%) had no renal cysts, and in 21 (14%), the presence of renal cysts was unknown because the cats did not undergo ultrasonography.

The PKD1 mutation rate in relation to the signalment of cats
------------------------------------------------------------

The results of genetic testing by breed are shown in [Table 2](#tbl_002){ref-type="table"}Table 2.The results of genetic test in relation to the breeds of catsBreedPositive (n)Negative (n)Positive rate (%)Total numberPersian cats36434679Exotic Shorthair16552371Scottish Fold37325469American Shorthair16184734Munchkin6103816Maine Coon22504Japanese mixed breed26225448Other western mixed breed837311. The *PKD1* mutation rate was 46% (36/79) in Persian cats. Other breeds with a high mutation rate (≥40%) were Scottish Fold, American Shorthair, Maine Coon, Japanese mixed breed, and other western mixed breed cats. In terms of sex difference, the rate of the *PKD1* mutation was 46% (77/166) in males and 37% (66/179) in females; the sex of 32 cats was unknown. The mutation rate did not differ significantly between male and female cats by χ^2^ test (*P*=0.357). The age distribution of cats with the *PKD1* mutation is shown in [Fig. 1](#fig_001){ref-type="fig"}Fig. 1.The age distribution of cats with the *PKD1* mutation.; the cats ranged from \>1 to 18 years old; the average (± SD) age was 5.4 ± 4.5 years old.

Evaluation of renal function in cats with the PKD1 mutation
-----------------------------------------------------------

One hundred and two cats with the *PKD1* mutation also had data on blood Cre concentration. The relationship of blood Cre concentration with age is shown in [Fig. 2](#fig_002){ref-type="fig"}Fig. 2.The relationship between blood creatinine concentration and the age of cats with the *PKD1* mutation.. Of cats with the *PKD1* mutation, the incidence of a high concentration of plasma Cre (\>1.6 mg/d*l*: ≥IRIS-CKD stage 2) was greater in cats older than 3 years old, and especially in those older than 7 years. In contrast, a few cats aged ≥9 years had low plasma Cre concentrations (≤1.6 mg/d*l*).

Coincidence of renal and hepatic cysts
--------------------------------------

The association between renal and hepatic cysts was also investigated. Co-occurrence of hepatic and renal cysts was found in 20 (12.6%) out of 159 cases with renal cyst(s), and all of these cases (13 males, 6 females, and 1 cat of unknown sex, 2 to 17 years old: 5.2 ± 4.4 years) were positive for the *PKD1* mutation. A significant difference in the *PKD1* mutation rate between male and female cats was not detected by χ^2^ test (*P*=0.44). The prevalence of co-occurrence of renal and hepatic cysts by breed is shown in [Table 3](#tbl_003){ref-type="table"}Table 3.The breeds of cats complicated with renal and hepatic cystsBreedCase number\
(Number of male cats)Prevalence\
(%) ^a)^Persian cats11 (7)31Scottish Fold3 (1)16Amerian Shorthair2 (2)12Other western-mixed breed1 (unknown)6Japanese-mixed breed2 (2)12Unkown1 (1)5Total20 (13)a) The prevalence in each cat breed.. Of note, Persian cats were overrepresented: 31% of all Persian cats examined had co-occurring renal and hepatic cysts, and a few cats of other breeds, including Scottish Fold and American Shorthair cats, had co-occurring cysts.

DISCUSSION {#s3}
==========

Since 2000, the prevalence of feline PKD have been investigated in several countries, including the United States, Italy, the United Kingdom, Australia, France, Slovenia and Taiwan \[[@r2], [@r3], [@r5], [@r10], [@r14], [@r20]\]. Many reports have identified the breeds at high risk for PKD, including Persians and Persian related breeds \[[@r2], [@r5], [@r6], [@r12], [@r15]\]. Since 2004, reports on the diagnosis of PKD using genetic testing have increased, and the *PKD1* mutation rate is reported to be 15.7% in Persian cats in Taiwan \[[@r20]\], 33.3% in Persian cats in Slovenia \[[@r14]\], and 37.1% in Persian cats and Exotic Shorthairs in Italy \[[@r8]\]. In our study, the *PKD1* mutation rate in Persian cats was 46%. When considering the breeding bias in previous studies and the present study, this rate is higher than previously reported. However, the samples used in this study were obtained from cases in which renal cysts were detected by ultrasonography, or from those related to cats with PKD, or from high risk breeds. Therefore, the true prevalence of the *PKD1* mutation in Persian cats in Japan is expected to be lower than that reported in the current study.

In recent reports from other countries, Persian related breeds such as Exotic Shorthair and British Shorthair are also at high risk for PKD, and the Bombay and Ragdoll breeds are at moderate risk \[[@r3], [@r23]\]. Polycystic kidney disease has been found in other breeds, including American Shorthair, Chinchilla, Irish Shorthair and Exotic Shorthair \[[@r20]\]. However, the incidence in these breeds is much lower than in Persian cats. Several studies from various parts of the world have reported that the prevalence of PKD detected by ultrasonography ranged from 37 to 49% in Persian and Persian related cats and was around 16% in other breeds \[[@r2], [@r3], [@r10]\]. In the present study, it was found that Scottish Fold and American Shorthair cats also had high rates in the *PKD1* mutation (a few cases were reported in previous studies). These results suggest that the disease is distributed among many breeds of cat in Japan. In addition, cats with the *PKD1* mutation may be blindly used for breeding with cats of other breeds.

In the present study, results of genetic evaluation were inconsistent with cyst formation detected by ultrasonography. Thirty-three cats with renal cysts detected by the referring veterinarians using ultrasonography showed negative by genetic testing for the *PKD1* mutation. Although renal cysts in PKD are detected easily by ultrasonography, hydronephrosis with dilated renal pelvis or renal cysts formed by dilation of urinary tubules in late stage of chronic nephritis can be mistaken as cysts of PKD \[[@r19]\]. Indeed, some reports have described cats of the Maine Coon breed in which renal cysts formed as a result of chronic nephritis but that did not have the *PKD1* mutation \[[@r18]\]. The results of ultrasonography often depend on the type of probe, the equipment used, and the technical skill of the operator. When we reviewed the ultrasonographic images sent by the referring veterinarians, many images were not consistent with cysts of PKD, whereas 3 cats diagnosed as having no cyst by the referring veterinarians were positive for the *PKD1* mutation. Two of these cats were very young (\<1 years old) and the age of the third cat was unknown. It is difficult to investigate the renal cysts in very young cats, especially those under 4 months old.

However, the possibility that another mutation exists at an unknown location cannot be excluded. The *PKD1* gene is very large and has 46 exons. In human ADPKD, it is known that the disease can be caused by mutations in the *PKD1* or *PKD2* gene, and nonsense or frameshifting mutation have been identified at various positions \[[@r22], [@r26]\]. Therefore, analysis of mutations at other positions in the feline *PKD1* and *PKD2* genes may also be needed in the future.

One clinical sign of PKD is an elevated serum Cre concentration. When cats with a high Cre concentration (corresponding to IRIS-CKD stageII or higher) were evaluated, the proportion tended to increase from 3 years old, and especially in those older than 7 years of age. However, some cats aged 9 or more had normal Cre concentration. These results suggested that clinical course in PKD is variable; in some cases, the disease progresses rapidly and results in azotemia, and in other cases, the disease progresses slowly, and renal function remains normal for a long time. In human ADPKD, the growth rate of cysts varies among patients and depends on the mutation position \[[@r11], [@r26]\]. In feline PKD, the disease-causing mutation is identified at only one position but, as described above, the possibility of mutation at other locations cannot be excluded. Recently, a "third hit hypothesis" was proposed to explain the pathogenesis in human ADPKD. In this hypothesis, the formation of cysts is hastened by presence of other complications affecting the renal parenchyma or function. Further investigation is required to clarify whether concurrent diseases, such as urolithiasis or urinary tract infection for example, affect cyst formation in PKD affected cats.

Hepatic cyst is an extrarenal manifestations that occurs in a few cases of PKD \[[@r9]\]. In humans with ADPKD, the rate of coincident renal and hepatic cysts is about 80% \[[@r1]\], whereas a few studies have reported coincident renal and hepatic cysts in cats \[[@r7], [@r9]\]. According to the research in Italy \[[@r7]\], 8 of 136 (5.9%) animals with renal cysts had one or more hepatic cysts concurrently; all of the cats were male Persian cats, but genetic testing was not performed. In our study, the rate of coincident renal and hepatic cysts was 12.6%, and all cases were positive for the *PKD1* mutation. Although not significantly different, more male than female cats were affected with coincident renal and hepatic cysts in the present study, which is similar to previous reports \[[@r7]\]. In addition, the incidence of hepatic cysts in PKD and the high prevalence in Persian cats in our study are consistent with these reports. The high incidence of hepatic cysts in Persian cats suggests that the incidence may differ among breeds. In human ADPKD, the incidence of hepatic cysts is higher in women, so this condition is thought to be related with pregnancy or female hormone \[[@r1], [@r16], [@r17]\]. In addition, hepatic cysts occurring in human ADPKD are thought to represent marked dilation of bile ducts in bile-duct hamartomas \[[@r13]\]. Pathological analysis of hepatic cysts in feline PKD shows that the cysts are lined with flattened epithelial cells and are not associated with other hepatobiliary lesions \[[@r15]\]. Therefore, hepatic cysts in feline PKD may have a different pathogenesis from those in human ADPKD, and other factors might be associated with this lesion in cats. Further investigation is required to determine the pathogenesis of hepatic cysts in feline PKD. Furthermore, there was no significant difference in age between cats with hepatic cysts and those without. Therefore, disease stage may not be related to hepatic cyst formation.

This study revealed the epidemiological features of the cats with the *PKD1* mutation in a large population of the cats suspected to have ADPKD. In contrast to results from other countries, the cats with the *PKD1* mutation are widely distributed in Japan, not only in Persian cats but also in non-Persians. Affected cats tend to develop signs of impaired renal function from as early as 3 years of age, and the clinical course can vary. In addition, relatively high coincidence of renal and hepatic cysts in the cats with the *PKD1* mutation was found. It is strongly recommended that cats positive for the *PKD1* mutation are not used for breeding.
